C5252
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C5252, covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor [Phase 1, Phase 2]